loadpatents
name:-0.0093448162078857
name:-0.004932165145874
name:-0.0080740451812744
Ludwig; Dale Lincoln Patent Filings

Ludwig; Dale Lincoln

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ludwig; Dale Lincoln.The latest application filed is for "anti-cd45-based lymphodepletion methods and uses thereof in conjction with act-based cancer therapies".

Company Profile
7.5.9
  • Ludwig; Dale Lincoln - Rockaway NJ
  • Ludwig; Dale Lincoln - Denville NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-PD-L1-anti-TIM-3 bispecific antibodies
Grant 11,351,251 - Li , et al. June 7, 2
2022-06-07
Checkpoint inhibitor bispecific antibodies
Grant 11,203,640 - Kalos , et al. December 21, 2
2021-12-21
Anti-cd45-based Lymphodepletion Methods And Uses Thereof In Conjction With Act-based Cancer Therapies
App 20210198359 - Berger; Mark ;   et al.
2021-07-01
Methods For Cancer Treatment Using A Radiolabeled Anti-cd45 Immunoglobulin And Adoptive Cell Therapies
App 20200308280 - Berger; Mark ;   et al.
2020-10-01
Anti-cd45-based Conditioning Methods And Uses Thereof In Conjunction With Gene-edited Cell-based Therapies
App 20200255520 - Kind Code
2020-08-13
Anti-canine platelet derived growth factor receptor alpha antibody
Grant 10,711,066 - Burtrum , et al.
2020-07-14
Anti-Canine Platelet Derived Growth Factor Receptor Alpha Antibody
App 20190300612 - BURTRUM; Douglas Bryan ;   et al.
2019-10-03
Anti-pd-l1-anti-tim-3 Bispecific Antibodies
App 20190247497 - LI; Yiwen ;   et al.
2019-08-15
PD-L1 Antibodies
App 20190144544 - Ludwig; Dale Lincoln ;   et al.
2019-05-16
Anti-PD-L1-anti-TIM-3 bispecific antibodies
Grant 10,279,034 - Li , et al.
2019-05-07
PD-L1 antibodies
Grant 10,214,586 - Ludwig , et al. Feb
2019-02-26
Checkpoint Inhibitor Bispecific Antibodies
App 20190010232 - Kalos; Michael Dewain ;   et al.
2019-01-10
Anti-pd-l1-anti-tim-3 Bispecific Antibodies
App 20180289803 - LI; Yiwen ;   et al.
2018-10-11
PD-L1 Antibodies
App 20170058033 - Ludwig; Dale Lincoln ;   et al.
2017-03-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed